Literature DB >> 24577568

HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P.

Florin Tuluc1, John Meshki2, Sergei Spitsin2, Steven D Douglas3.   

Abstract

Activation of NK1R by SP contributes to increased HIV-1 infection in macrophages. The scavenger receptor CD163 is expressed on cells of monocyte-macrophage origin. Our main goal was to determine if there is interplay among SP, CD163 expression, and HIV infection in macrophages. We showed that SP triggers intracellular calcium elevation and increased CD163 expression in human monocytes in a time- and concentration-dependent manner. The role of CD163 on HIV infection was examined by RT-PCR in sorted monocytes (CD163(low) and CD163(high)) and in macrophages having CD163 knocked down using siRNA. We found that the productivity of HIV infection was higher in CD163(high) cells. Additionally, in macrophages with CD163 expression knocked down, we found a significant decrease of HIV infection. Furthermore, Hb-Hp complexes, which function as an endogenous ligand for CD163, decreased HIV infection in macrophages in a dose-dependent manner. Thus, we demonstrate that SP induces higher levels of CD163 in monocytes and that high expression of CD163 is associated with increases HIV infection in macrophages. Thus, in addition to being a prognostic marker of HIV infection, the expression of CD163 on macrophages may be critical in HIV immunopathogenesis.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  AIDS; haptoglobin; hemoglobin; monocytes; neurocognitive impairment

Mesh:

Substances:

Year:  2014        PMID: 24577568      PMCID: PMC4056276          DOI: 10.1189/jlb.4AB0813-434RR

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  40 in total

1.  Recently infiltrating MAC387(+) monocytes/macrophages a third macrophage population involved in SIV and HIV encephalitic lesion formation.

Authors:  Caroline Soulas; Cecily Conerly; Woong-Ki Kim; Tricia H Burdo; Xavier Alvarez; Andrew A Lackner; Kenneth C Williams
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Soluble CD163.

Authors:  Holger J Møller
Journal:  Scand J Clin Lab Invest       Date:  2011-11-07       Impact factor: 1.713

3.  Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals.

Authors:  Mark M Manak; Dmitry A Moshkoff; Lequan T Nguyen; John Meshki; Pablo Tebas; Florin Tuluc; Steven D Douglas
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

Review 4.  Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation.

Authors:  Steven D Douglas; Susan E Leeman
Journal:  Ann N Y Acad Sci       Date:  2010-11-22       Impact factor: 5.691

5.  Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.

Authors:  Tricia H Burdo; Janet Lo; Suhny Abbara; Jeffrey Wei; Michelle E DeLelys; Fred Preffer; Eric S Rosenberg; Kenneth C Williams; Steven Grinspoon
Journal:  J Infect Dis       Date:  2011-10-15       Impact factor: 5.226

6.  In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis.

Authors:  Juan Antonio Moreno; Almudena Ortega-Gómez; Sandrine Delbosc; Nathalie Beaufort; Emmanuel Sorbets; Liliane Louedec; Marina Esposito-Farèse; Florence Tubach; Antonino Nicoletti; Philippe Gabriel Steg; Jean-Baptiste Michel; Laurent Feldman; Olivier Meilhac
Journal:  Eur Heart J       Date:  2011-05-23       Impact factor: 29.983

7.  Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.

Authors:  Tricia H Burdo; Margaret R Lentz; Patrick Autissier; Anitha Krishnan; Elkan Halpern; Scott Letendre; Eric S Rosenberg; Ronald J Ellis; Kenneth C Williams
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

8.  Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.

Authors:  Emma Tippett; Wan-Jung Cheng; Clare Westhorpe; Paul U Cameron; Bruce J Brew; Sharon R Lewin; Anthony Jaworowski; Suzanne M Crowe
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

9.  Identification of the CD163 protein domains involved in infection of the porcine reproductive and respiratory syndrome virus.

Authors:  Hanne Van Gorp; Wander Van Breedam; Jan Van Doorsselaere; Peter L Delputte; Hans J Nauwynck
Journal:  J Virol       Date:  2009-12-23       Impact factor: 5.103

10.  Substance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent manner.

Authors:  John Meshki; Steven D Douglas; Mingyue Hu; Susan E Leeman; Florin Tuluc
Journal:  PLoS One       Date:  2011-09-23       Impact factor: 3.240

View more
  17 in total

1.  CD44 variant isoform 9 emerges in response to injury and contributes to the regeneration of the gastric epithelium.

Authors:  Nina Bertaux-Skeirik; Mark Wunderlich; Emma Teal; Jayati Chakrabarti; Jacek Biesiada; Maxime Mahe; Nambirajan Sundaram; Joel Gabre; Jennifer Hawkins; Gao Jian; Amy C Engevik; Li Yang; Jiang Wang; James R Goldenring; Joseph E Qualls; Mario Medvedovic; Michael A Helmrath; Tayyab Diwan; James C Mulloy; Yana Zavros
Journal:  J Pathol       Date:  2017-08       Impact factor: 7.996

2.  Farm animal models of organic dust exposure and toxicity: insights and implications for respiratory health.

Authors:  Chakia J McClendon; Carresse L Gerald; Jenora T Waterman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-04

3.  Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection.

Authors:  Dionna W Williams; Elizabeth L Engle; Erin N Shirk; Suzanne E Queen; Lucio Gama; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  Am J Pathol       Date:  2016-06-18       Impact factor: 4.307

4.  Substance P-mediated chemokine production promotes monocyte migration.

Authors:  Sergei Spitsin; John Meshki; Angela Winters; Florin Tuluc; Tami D Benton; Steven D Douglas
Journal:  J Leukoc Biol       Date:  2016-10-21       Impact factor: 4.962

5.  Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches.

Authors:  Steven D Douglas
Journal:  Br J Haematol       Date:  2016-08-19       Impact factor: 6.998

Review 6.  Pulmonary Innate Immune Dysfunction in Human Immunodeficiency Virus.

Authors:  Bashar S Staitieh; Eduardo E Egea; David M Guidot
Journal:  Am J Respir Cell Mol Biol       Date:  2017-05       Impact factor: 6.914

Review 7.  Neuropeptide substance P and the immune response.

Authors:  Alireza Mashaghi; Anna Marmalidou; Mohsen Tehrani; Peter M Grace; Charalabos Pothoulakis; Reza Dana
Journal:  Cell Mol Life Sci       Date:  2016-06-17       Impact factor: 9.261

Review 8.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms.

Authors:  Tamás Rőszer
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

9.  Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

Authors:  A R Kallianpur; H Gittleman; S Letendre; R Ellis; J S Barnholtz-Sloan; W S Bush; R Heaton; D C Samuels; D R Franklin; D Rosario-Cookson; D B Clifford; A C Collier; B Gelman; C M Marra; J C McArthur; J A McCutchan; S Morgello; I Grant; D Simpson; J R Connor; T Hulgan
Journal:  Mol Neurobiol       Date:  2018-09-12       Impact factor: 5.682

10.  Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults.

Authors:  Pablo Tebas; Sergei Spitsin; Jeffrey S Barrett; Florin Tuluc; Okan Elci; James J Korelitz; Wayne Wagner; Angela Winters; Deborah Kim; Renae Catalano; Dwight L Evans; Steven D Douglas
Journal:  AIDS       Date:  2015-05-15       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.